Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3941-3950 of 4090 results

Catalogue Number:

PX-TA1494

Category:

G

Proteo Genix logo

Tibulizumab Biosimilar – Anti-IL17A/ TNFSF13B/ CD257 mAb – Research Grade

Target: IL17A/ TNFSF13B/ CD257
Target Alias Name: Tibulizumab/LY 3090106/LY-3090106/LY3090106/IL17A/ TNFSF13B/ CD257/anti-IL17A/ TNFSF13B/ CD257
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa-[scFv]2
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1565

Category:

G

Proteo Genix logo

Tidutamab Biosimilar – Anti-CD3 epsilon/ SSTR2 mAb – Research Grade

Target: CD3 epsilon/ SSTR2
Target Alias Name: Tidutamab /XmAb-18087/CD3 epsilon/ SSTR2/anti-CD3 epsilon/ SSTR2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa / scFv-h-CH2-CH3
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1886

Category:

G

Proteo Genix logo

Tifcemalimab Biosimilar – Anti-BTLA mAb – Research Grade

Target: BTLA
Target Alias Name: Tifcemalimab//BTLA/anti-BTLA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1168

Category:

G

Proteo Genix logo

Tigatuzumab Biosimilar – Anti-TNFRSF10B/ CD262 mAb – Research Grade

Target: TNFRSF10B/ CD262
Target Alias Name: Tigatuzumab/CS-1008/TRA-8/TNFRSF10B/ CD262/anti-TNFRSF10B/ CD262
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1404

Category:

G

Proteo Genix logo

Tilavonemab Biosimilar – Anti-MAPT mAb – Research Grade

Target: MAPT
Target Alias Name: Tilavonemab /ABBV-8E12/ C2N-8E12/MAPT/anti-MAPT
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1309

Category:

G

Proteo Genix logo

Tildrakizumab Biosimilar – Anti-IL23A mAb – Research Grade

Target: IL23A
Target Alias Name: Tildrakizumab/MK-3222/ SCH900222/IL23A/anti-IL23A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1725

Category:

G

Proteo Genix logo

Tilogotamab Biosimilar – Anti-TNFRSF10B mAb – Research Grade

Target: TNFRSF10B
Target Alias Name: Tilogotamab/IMMUNOGLOBULIN G1 (430-GLYCINE)/ ANTI-(HUMAN DEATH RECEPTOR 5) (HUMAN MONOCLONAL HEXABODY-DR5-05 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN MONOCLONAL HEXABODY-DR5-05 .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G1/ ANTI-(HUMAN DEATH RECEPTOR 5) (HUMAN 1029-05 1-CHAIN)/ DISULFIDE WITH HUMAN 1029-05-CHAIN/ DIMER/TNFRSF10B/anti-TNFRSF10B
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1608

Category:

G

Proteo Genix logo

Tilvestamab Biosimilar – Anti-AXL mAb – Research Grade

Target: AXL
Target Alias Name: Tilvestamab /Ab-2/BGB-149/AXL/anti-AXL
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1474

Category:

G

Proteo Genix logo

Timigutuzumab Biosimilar – Anti-ERBB2/ EGFR2/ CD340 mAb – Research Grade

Target: ERBB2/ EGFR2/ CD340
Target Alias Name: Timigutuzumab/GEXMab73/GT-MAb7.3-GEX/TrastuzuMab-GEX/ERBB2/ EGFR2/ CD340/anti-ERBB2/ EGFR2/ CD340
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1422

Category:

G

Proteo Genix logo

Timolumab Biosimilar – Anti-AOC3/ VAP1 mAb – Research Grade

Target: AOC3/ VAP1
Target Alias Name: Timolumab/8c10/BTT-1023/BTT1023/SI-3106/SI-636/r8c10/AOC3/ VAP1/anti-AOC3/ VAP1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo